Back to search

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysis

Data up to Jan 2025

Published2006
Citations142
References54

Total Citations Per Year

Abstract

References (54)

Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies

2004 • 691 citations

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

1996 • 473 citations

Risk of Tardive Dyskinesia in Older Patients

1995 • 302 citations

Statistical Methods in Genetic Epidemiology

2004 • 286 citations

Tardive Dyskinesia

1988 • 271 citations

Gender Differences in Tardive Dyskinesia: A Critical Review of the Literature

1992 • 258 citations

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1997 • 242 citations

Pharmacogenetics of Tardive Dyskinesia Combined Analysis of 780 Patients Supports Association with Dopamine D3 Receptor Gene Ser9Gly Polymorphism

2002 • 241 citations

D3 dopamine receptor mRNA is widely expressed in the human brain

1998 • 237 citations

Proposed Schizophrenia-Related Gene Polymorphism: Expression of the Ser9Gly Mutant Human Dopamine D3Receptor with the Semliki Forest Virus System

1996 • 233 citations

Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia

1999 • 163 citations

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1999 • 153 citations

Antipsychotic Polypharmacy: A Survey of Discharge Prescriptions from a Tertiary Care Psychiatric Institution

2001 • 129 citations

Dyskinesia. Research and treatment.

1985 • 126 citations

Pharmacogenomics in schizophrenia: the quest for individualized therapy

2002 • 125 citations

Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis

2003 • 110 citations

CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis

2005 • 100 citations

Familial occurrence of tardive dyskinesia

2001 • 99 citations

Relationship between adverse effects of antipsychotic treatment and dopamine D2 receptor polymorphisms in patients with schizophrenia

2002 • 92 citations

Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism

2006 • 87 citations

Association between the Ser9Gly Polymorphism of the Dopamine D3 Receptor Gene and Tardive Dyskinesia in Chinese Schizophrenic Patients

2001 • 84 citations

Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia

1996 • 80 citations

Tardive dyskinesia: who is at risk?

1997 • 77 citations

Neuroleptic-induced Movement Disorders: An Overview

2005 • 76 citations

Intermittent Neuroleptic Treatment and Risk for Tardive Dyskinesia: Curaçao Extrapyramidal Syndromes Study III

1998 • 72 citations

Race and Tardive Dyskinesia Among Outpatients at a CMHC

1994 • 69 citations

Tardive Drug-Induced Extrapyramidal Syndromes

2000 • 69 citations

Association Analysis of the Dopamine D3 Receptor Gene ser9gly and Brain-Derived Neurotrophic Factor Gene val66met Polymorphisms With Antipsychotic-Induced Persistent Tardive Dyskinesia and Clinical Expression in Chinese Schizophrenic Patients

2004 • 69 citations

Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms

2005 • 67 citations

Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism

2004 • 65 citations

Dopamine D3 receptor variant and tardive dyskinesia

2000 • 65 citations

Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia

2002 • 64 citations

Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.

2005 • 60 citations

Clinical implications of pharmacogenomics for tardive dyskinesia

2004 • 58 citations

Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia

2003 • 54 citations

Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment

2004 • 54 citations

Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

2001 • 50 citations

Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics

2002 • 49 citations

Effects of Antipsychotic Treatment on Tardive Dyskinesia

2005 • 48 citations

Tardive dyskinesia in psychosis: are women really more at risk?

1999 • 47 citations

Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients

2000 • 45 citations

Assessment of association of D3 dopamine receptorMscI polymorphism with schizophrenia: Analysis of symptom ratings, family history, age at onset, and movement disorders

1996 • 44 citations

Pharmacogenetics of Psychotropic Drugs

2002 • 38 citations

Spontaneous dyskinesia in first-degree relatives of chronically ill, never-treated people with schizophrenia

2003 • 36 citations

Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms

2004 • 35 citations

Search for a Susceptibility Locus to Tardive Dyskinesia

1997 • 30 citations

No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample

2005 • 28 citations

Statistical Methods in Genetic Epidemiology.

2004 • 28 citations

Historical perspective on movement disorders.

2004 • 27 citations

Search for a Susceptibility Locus to Tardive Dyskinesia

1997 • 27 citations

Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study

2000 • 19 citations

Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study

2000 • 13 citations

Pharmacogenetics of Psychotropic Drugs

2003 • 10 citations

Diabetes mellitus and tardive dyskinesia

1996 • 10 citations

Cited By (0)

Loading...